The maker of a promising ovarian cancer drug said, Friday, that he stopped enrolling women in a study because several patients developed gastrointestinal holes.
The maker of a promising ovarian cancer drug is older than 30.
( z1 have-degree :ARG1 ( z2 company :ARG0-of ( z3 make :ARG1 ( z4 drug :ARG0-of ( z5 promise ) :purpose ( z6 disease :name ( z7 name :op "ovarian" :op "cancer" ) ) ) ) ) :ARG2 ( z8 old ) :ARG3 ( z9 more ) :ARG4 ( z10 temporal-quantity :quant 30 :unit ( z11 year ) ) )